| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.704 | 0.002 | 0.704 | Vasopressin 1A antagonist | 0.133 0.005 DBMET02114 | ||
| 0.695 | 0.002 | 0.695 | Vasopressin 1 antagonist | 0.155 0.005 DBMET02114 | ||
| 0.684 | 0.002 | 0.684 | Oxytocin antagonist | 0.234 0.004 DBMET02114 | ||
| 0.651 | 0.03 | 0.704 | Caspase 9 stimulant | 0.704 0.023 DBMET02114 | DBMET02114 | |
| 0.606 | 0.002 | 0.606 | Vasopressin 2 antagonist | 0.121 0.004 DBMET02114 | ||
| 0.595 | 0.002 | 0.595 | Vasopressin 1B antagonist | 0.121 0.004 DBMET02114 | ||
| 0.589 | 0.003 | 0.589 | Antidiuretic hormone antagonist | 0.115 0.01 DBMET02114 | ||
| 0.575 | 0.022 | 0.621 | Cholesterol antagonist | 0.621 0.016 DBMET02114 | DBMET02114 | |
| 0.591 | 0.051 | 0.598 | Apoptosis agonist | 0.598 0.049 DBMET02114 | DBMET02114 | |
| 0.536 | 0.022 | 0.536 | 5 Hydroxytryptamine release stimulant | 0.397 0.046 DBMET02114 | ||
| 0.506 | 0.01 | 0.506 | Psychostimulant | 0.306 0.041 DBMET02114 | ||
| 0.497 | 0.021 | 0.538 | Apoptosis antagonist | 0.538 0.016 DBMET02114 | DBMET02114 | |
| 0.48 | 0.006 | 0.48 | Platelet adhesion inhibitor | 0.366 0.016 DBMET02114 | ||
| 0.503 | 0.032 | 0.503 | Aldehyde oxidase inhibitor | 0.388 0.049 DBMET02114 | ||
| 0.472 | 0.049 | 0.557 | Transcription factor NF kappa B inhibitor | 0.557 0.037 DBMET02114 | DBMET02114 | |
| 0.425 | 0.007 | 0.534 | Lipocortins synthesis antagonist | 0.534 0.003 DBMET02114 | DBMET02114 | |
| 0.438 | 0.021 | 0.499 | Nitric oxide antagonist | 0.499 0.016 DBMET02114 | DBMET02114 | |
| 0.416 | 0.019 | 0.416 | Calcium channel activator | 0.389 0.029 DBMET02114 | ||
| 0.411 | 0.014 | 0.465 | Sodium/bile acid cotransporter inhibitor | 0.465 0.006 DBMET02114 | DBMET02114 | |
| 0.416 | 0.023 | 0.416 | Interleukin 2 agonist | 0.407 0.025 DBMET02114 | ||
| 0.481 | 0.096 | 0.799 | Antiinflammatory | 0.799 0.015 DBMET02114 | DBMET02114 | |
| 0.407 | 0.028 | 0.407 | Cardiotonic | 0.288 0.062 DBMET02114 | ||
| 0.379 | 0.008 | 0.513 | Antipruritic | 0.513 0.004 DBMET02114 | DBMET02114 | |
| 0.434 | 0.073 | 0.434 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.315 0.192 DBMET02114 | ||
| 0.343 | 0.002 | 0.343 | CXC chemokine 3 receptor antagonist | 0.05 0.009 DBMET02114 | ||
| 0.379 | 0.039 | 0.446 | Antioxidant | 0.446 0.027 DBMET02114 | DBMET02114 | |
| 0.37 | 0.033 | 0.497 | Tumour necrosis factor alpha release inhibitor | 0.497 0.014 DBMET02114 | DBMET02114 | |
| 0.345 | 0.014 | 0.429 | Interferon gamma antagonist | 0.429 0.009 DBMET02114 | DBMET02114 | |
| 0.339 | 0.01 | 0.339 | Neurotrophic factor enhancer | 0.312 0.015 DBMET02114 | ||
| 0.344 | 0.025 | 0.365 | Anesthetic general | 0.365 0.021 DBMET02114 | DBMET02114 | |
| 0.345 | 0.027 | 0.345 | 5 Hydroxytryptamine uptake stimulant | 0.301 0.044 DBMET02114 | ||
| 0.32 | 0.005 | 0.32 | Estrogen agonist | 0.284 0.005 DBMET02114 | ||
| 0.319 | 0.005 | 0.319 | Aromatase inhibitor | 0.177 0.01 DBMET02114 | ||
| 0.331 | 0.022 | 0.406 | Hepatoprotectant | 0.406 0.013 DBMET02114 | DBMET02114 | |
| 0.281 | 0.002 | 0.281 | RNA-directed RNA polymerase stimulant | 0.186 0.003 DBMET02114 | ||
| 0.279 | 0.004 | 0.279 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.145 0.006 DBMET02114 | ||
| 0.284 | 0.013 | 0.348 | Cholesterol synthesis inhibitor | 0.348 0.007 DBMET02114 | DBMET02114 | |
| 0.349 | 0.087 | 0.349 | GABA C receptor rho-3 antagonist | 0.234 0.169 DBMET02114 | ||
| 0.302 | 0.047 | 0.302 | Interleukin agonist | 0.277 0.06 DBMET02114 | ||
| 0.256 | 0.005 | 0.28 | Arachidonic acid antagonist | 0.28 0.003 DBMET02114 | DBMET02114 | |
| 0.242 | 0.011 | 0.264 | Microtubule formation inhibitor | 0.264 0.005 DBMET02114 | DBMET02114 | |
| 0.341 | 0.123 | 0.341 | 5 Hydroxytryptamine release inhibitor | 0.324 0.14 DBMET02114 | ||
| 0.228 | 0.011 | 0.256 | Androgen antagonist | 0.256 0.009 DBMET02114 | DBMET02114 | |
| 0.223 | 0.007 | 0.276 | Adenylate cyclase stimulant | 0.276 0.003 DBMET02114 | DBMET02114 | |
| 0.33 | 0.114 | 0.396 | Antibacterial | 0.396 0.079 DBMET02114 | DBMET02114 | |
| 0.271 | 0.057 | 0.271 | Gastrin inhibitor | 0.251 0.078 DBMET02114 | ||
| 0.218 | 0.007 | 0.218 | Pregnane X receptor agonist | 0.181 0.018 DBMET02114 | ||
| 0.214 | 0.005 | 0.214 | Cannabinoid CB2 receptor antagonist | |||
| 0.317 | 0.115 | 0.317 | Histamine release inhibitor | 0.282 0.134 DBMET02114 | ||
| 0.285 | 0.087 | 0.388 | Caspase 3 stimulant | 0.388 0.048 DBMET02114 | DBMET02114 | |
| 0.198 | 0.004 | 0.22 | Anabolic | 0.22 0.003 DBMET02114 | DBMET02114 | |
| 0.195 | 0.005 | 0.195 | CXC chemokine receptor antagonist | |||
| 0.233 | 0.062 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.248 0.05 DBMET02114 | DBMET02114 | |
| 0.176 | 0.006 | 0.176 | 5-Alpha-reductase inhibitor | 0.165 0.006 DBMET02114 | ||
| 0.207 | 0.039 | 0.282 | Protein kinase stimulant | 0.282 0.019 DBMET02114 | DBMET02114 | |
| 0.173 | 0.006 | 0.232 | Androgen agonist | 0.232 0.004 DBMET02114 | DBMET02114 | |
| 0.202 | 0.04 | 0.298 | Melanin inhibitor | 0.298 0.022 DBMET02114 | DBMET02114 | |
| 0.251 | 0.091 | 0.251 | Spasmolytic | 0.174 0.142 DBMET02114 | ||
| 0.239 | 0.079 | 0.239 | Tyrosine 3 hydroxylase inhibitor | 0.211 0.117 DBMET02114 | ||
| 0.186 | 0.026 | 0.204 | Farnesoid X receptor antagonist | 0.204 0.02 DBMET02114 | DBMET02114 | |
| 0.204 | 0.046 | 0.204 | Succinate dehydrogenase inhibitor | 0.191 0.057 DBMET02114 | ||
| 0.233 | 0.08 | 0.346 | DNA synthesis inhibitor | 0.346 0.031 DBMET02114 | DBMET02114 | |
| 0.222 | 0.072 | 0.349 | Antimitotic | 0.349 0.033 DBMET02114 | DBMET02114 | |
| 0.158 | 0.011 | 0.158 | CDC25A inhibitor | 0.116 0.02 DBMET02114 | ||
| 0.163 | 0.02 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 DBMET02114 | DBMET02114 | |
| 0.161 | 0.02 | 0.161 | Estrogen antagonist | 0.16 0.02 DBMET02114 | ||
| 0.148 | 0.008 | 0.169 | Glycine receptor antagonist | 0.169 0.005 DBMET02114 | DBMET02114 | |
| 0.144 | 0.005 | 0.144 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.101 0.01 DBMET02114 | ||
| 0.176 | 0.042 | 0.303 | Alpha-N-acetylglucosaminidase inhibitor | 0.303 0.016 DBMET02114 | DBMET02114 | |
| 0.145 | 0.013 | 0.145 | Ornithine decarboxylase inhibitor | 0.112 0.032 DBMET02114 | ||
| 0.183 | 0.052 | 0.183 | Interleukin 6 antagonist | 0.176 0.058 DBMET02114 | ||
| 0.135 | 0.004 | 0.135 | 5-Alpha-reductase 2 inhibitor | 0.046 0.007 DBMET02114 | ||
| 0.139 | 0.008 | 0.156 | Na+ K+ transporting ATPase inhibitor | 0.156 0.005 DBMET02114 | DBMET02114 | |
| 0.166 | 0.036 | 0.281 | Adenylate cyclase inhibitor | 0.281 0.015 DBMET02114 | DBMET02114 | |
| 0.144 | 0.015 | 0.144 | Keratolytic | 0.127 0.019 DBMET02114 | ||
| 0.179 | 0.054 | 0.179 | Diuretic | 0.179 0.054 DBMET02114 | ||
| 0.156 | 0.032 | 0.156 | GABA C receptor agonist | 0.134 0.041 DBMET02114 | ||
| 0.129 | 0.004 | 0.129 | Estrone sulfatase inhibitor | 0.027 0.012 DBMET02114 | ||
| 0.198 | 0.074 | 0.324 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.324 0.017 DBMET02114 | DBMET02114 | |
| 0.13 | 0.006 | 0.13 | Aldosterone antagonist | 0.106 0.008 DBMET02114 | ||
| 0.227 | 0.104 | 0.236 | Transcription factor STAT3 inhibitor | 0.236 0.095 DBMET02114 | DBMET02114 | |
| 0.179 | 0.062 | 0.211 | Phospholipase C inhibitor | 0.211 0.038 DBMET02114 | DBMET02114 | |
| 0.119 | 0.004 | 0.119 | Heme oxygenase stimulant | 0.084 0.013 DBMET02114 | ||
| 0.137 | 0.024 | 0.137 | Acetylcholine nicotinic antagonist | |||
| 0.12 | 0.007 | 0.12 | Bombesin 3 receptor antagonist | |||
| 0.129 | 0.016 | 0.14 | Estrogen receptor alpha antagonist | 0.14 0.013 DBMET02114 | DBMET02114 | |
| 0.133 | 0.022 | 0.133 | Estrogen receptor beta antagonist | 0.127 0.026 DBMET02114 | ||
| 0.133 | 0.023 | 0.133 | ABCA1 expression enhancer | 0.105 0.044 DBMET02114 | ||
| 0.121 | 0.012 | 0.122 | Glycine receptor agonist | 0.122 0.012 DBMET02114 | DBMET02114 | |
| 0.134 | 0.026 | 0.134 | Potassium channel activator | 0.094 0.055 DBMET02114 | ||
| 0.111 | 0.004 | 0.111 | 5-Alpha-reductase 1 inhibitor | 0.028 0.009 DBMET02114 | ||
| 0.125 | 0.019 | 0.125 | Glutamate release inhibitor | 0.094 0.053 DBMET02114 | ||
| 0.14 | 0.036 | 0.14 | GABA C receptor antagonist | 0.117 0.055 DBMET02114 | ||
| 0.238 | 0.136 | 0.31 | Antithrombotic | 0.31 0.082 DBMET02114 | DBMET02114 | |
| 0.111 | 0.009 | 0.111 | Estradiol 17 beta-dehydrogenase inhibitor | 0.069 0.016 DBMET02114 | ||
| 0.105 | 0.004 | 0.111 | Adenylate cyclase 1 inhibitor | 0.111 0.004 DBMET02114 | DBMET02114 | |
| 0.102 | 0.003 | 0.102 | Glucose-6-phosphate dehydrogenase inhibitor | 0.072 0.005 DBMET02114 | ||
| 0.102 | 0.005 | 0.143 | Lipocortins synthesis agonist | 0.143 0.002 DBMET02114 | DBMET02114 | |
| 0.222 | 0.127 | 0.329 | Hypoxia-inducible factor 1 alpha inhibitor | 0.329 0.053 DBMET02114 | DBMET02114 | |
| 0.099 | 0.004 | 0.099 | Pregnane X receptor antagonist | 0.086 0.005 DBMET02114 | ||
| 0.126 | 0.034 | 0.126 | Prolactin inhibitor | |||
| 0.116 | 0.024 | 0.121 | Bile acid receptor antagonist | 0.121 0.019 DBMET02114 | DBMET02114 | |
| 0.116 | 0.027 | 0.153 | Transcription factor NF kappa B stimulant | 0.153 0.015 DBMET02114 | DBMET02114 | |
| 0.114 | 0.028 | 0.114 | Inducible nitric-oxide synthase inhibitor | 0.092 0.044 DBMET02114 | ||
| 0.241 | 0.155 | 0.48 | Immunosuppressant | 0.48 0.039 DBMET02114 | DBMET02114 | |
| 0.089 | 0.005 | 0.089 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET02114 | ||
| 0.139 | 0.054 | 0.139 | Anesthetic local | |||
| 0.154 | 0.069 | 0.166 | CF transmembrane conductance regulator agonist | 0.166 0.052 DBMET02114 | DBMET02114 | |
| 0.2 | 0.116 | 0.2 | DNA damaging | |||
| 0.2 | 0.117 | 0.205 | Superoxide dismutase inhibitor | 0.205 0.112 DBMET02114 | DBMET02114 | |
| 0.135 | 0.053 | 0.14 | CC chemokine 6 receptor antagonist | 0.14 0.039 DBMET02114 | DBMET02114 | |
| 0.103 | 0.021 | 0.103 | Estrogen-related receptor beta agonist | 0.096 0.03 DBMET02114 | ||
| 0.084 | 0.005 | 0.084 | GABA uptake inhibitor | 0.037 0.031 DBMET02114 | ||
| 0.096 | 0.017 | 0.096 | Carbonic anhydrase VB inhibitor | |||
| 0.088 | 0.013 | 0.1 | Estrogen receptor beta agonist | 0.1 0.011 DBMET02114 | DBMET02114 | |
| 0.196 | 0.123 | 0.324 | Immunostimulant | 0.324 0.072 DBMET02114 | DBMET02114 | |
| 0.101 | 0.028 | 0.101 | Cannabinoid receptor antagonist | |||
| 0.125 | 0.053 | 0.125 | TRPA1 agonist | |||
| 0.134 | 0.063 | 0.134 | Cyclooxygenase 3 inhibitor | 0.122 0.075 DBMET02114 | ||
| 0.081 | 0.011 | 0.091 | Estrogen receptor alpha agonist | 0.091 0.01 DBMET02114 | DBMET02114 | |
| 0.074 | 0.005 | 0.074 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.034 0.008 DBMET02114 | ||
| 0.095 | 0.027 | 0.095 | Carbonic anhydrase VA inhibitor | |||
| 0.202 | 0.135 | 0.216 | Transcription factor STAT inhibitor | 0.216 0.117 DBMET02114 | DBMET02114 | |
| 0.073 | 0.006 | 0.073 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.038 0.017 DBMET02114 | ||
| 0.077 | 0.011 | 0.077 | Progesterone antagonist | 0.07 0.012 DBMET02114 | ||
| 0.071 | 0.006 | 0.071 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.069 0.006 DBMET02114 | ||
| 0.071 | 0.006 | 0.071 | Parathyroid hormone antagonist | 0.048 0.025 DBMET02114 | ||
| 0.071 | 0.007 | 0.082 | Farnesoid X receptor agonist | 0.082 0.005 DBMET02114 | DBMET02114 | |
| 0.136 | 0.071 | 0.136 | Bone formation stimulant | 0.113 0.092 DBMET02114 | ||
| 0.177 | 0.113 | 0.177 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.11 | 0.046 | 0.143 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.143 0.029 DBMET02114 | DBMET02114 | |
| 0.071 | 0.01 | 0.071 | Retinoid X receptor agonist | |||
| 0.091 | 0.03 | 0.091 | Carbonic anhydrase V inhibitor | |||
| 0.067 | 0.008 | 0.072 | Microtubule stabilization | 0.072 0.005 DBMET02114 | DBMET02114 | |
| 0.123 | 0.066 | 0.142 | DNA polymerase I inhibitor | 0.142 0.053 DBMET02114 | DBMET02114 | |
| 0.118 | 0.06 | 0.118 | Photosensitizer | 0.116 0.062 DBMET02114 | ||
| 0.079 | 0.025 | 0.094 | Glutamate (mGluR6) antagonist | 0.094 0.013 DBMET02114 | DBMET02114 | |
| 0.057 | 0.006 | 0.057 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.038 0.009 DBMET02114 | ||
| 0.061 | 0.011 | 0.117 | Glucocorticoid antagonist | 0.117 0.004 DBMET02114 | DBMET02114 | |
| 0.104 | 0.056 | 0.163 | UDP-glucose 4-epimerase inhibitor | 0.163 0.025 DBMET02114 | DBMET02114 | |
| 0.088 | 0.042 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.108 | 0.063 | 0.108 | Ferrochelatase inhibitor | |||
| 0.124 | 0.079 | 0.124 | Vanilloid 1 agonist | 0.116 0.098 DBMET02114 | ||
| 0.162 | 0.117 | 0.196 | Insulin sensitizer | 0.196 0.078 DBMET02114 | DBMET02114 | |
| 0.057 | 0.016 | 0.057 | Geranyltranstransferase inhibitor | 0.041 0.035 DBMET02114 | ||
| 0.095 | 0.053 | 0.127 | Triose-phosphate isomerase inhibitor | 0.127 0.029 DBMET02114 | DBMET02114 | |
| 0.103 | 0.062 | 0.142 | Adenylate kinase inhibitor | 0.142 0.029 DBMET02114 | DBMET02114 | |
| 0.099 | 0.057 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | 0.107 0.046 DBMET02114 | DBMET02114 | |
| 0.135 | 0.095 | 0.135 | Heat shock protein 70 antagonist | 0.131 0.115 DBMET02114 | ||
| 0.072 | 0.031 | 0.072 | NMDA 2C receptor antagonist | |||
| 0.117 | 0.077 | 0.117 | Cholinergic antagonist | |||
| 0.115 | 0.075 | 0.115 | Acetylcholine antagonist | |||
| 0.059 | 0.02 | 0.059 | Mineralocorticoid receptor antagonist | 0.049 0.032 DBMET02114 | ||
| 0.069 | 0.03 | 0.069 | Cannabinoid CB2 receptor agonist | |||
| 0.177 | 0.138 | 0.254 | Hypoglycemic | 0.254 0.075 DBMET02114 | DBMET02114 | |
| 0.047 | 0.009 | 0.054 | Tubulin agonist | 0.054 0.007 DBMET02114 | DBMET02114 | |
| 0.098 | 0.061 | 0.098 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.222 | 0.185 | 0.222 | Antiobesity | |||
| 0.104 | 0.069 | 0.104 | DOPA decarboxylase inhibitor | 0.094 0.088 DBMET02114 | ||
| 0.057 | 0.023 | 0.057 | Potassium channel Kv1.3 blocker | 0.041 0.04 DBMET02114 | ||
| 0.204 | 0.171 | 0.271 | Vasodilator, peripheral | 0.271 0.113 DBMET02114 | DBMET02114 | |
| 0.038 | 0.005 | 0.041 | Hedgehog signaling activator | 0.041 0.004 DBMET02114 | DBMET02114 | |
| 0.078 | 0.045 | 0.078 | Vanilloid 4 agonist | 0.078 0.044 DBMET02114 | ||
| 0.047 | 0.015 | 0.047 | Retinoid X alpha receptor agonist | |||
| 0.051 | 0.02 | 0.055 | Guanylate cyclase inhibitor | 0.055 0.016 DBMET02114 | DBMET02114 | |
| 0.059 | 0.028 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.032 | 0.003 | 0.049 | Telomerase stimulant | 0.049 0.001 DBMET02114 | DBMET02114 | |
| 0.074 | 0.045 | 0.129 | Phosphofructokinase-1 inhibitor | 0.129 0.023 DBMET02114 | DBMET02114 | |
| 0.132 | 0.104 | 0.371 | Growth hormone agonist | 0.371 0.02 DBMET02114 | DBMET02114 | |
| 0.04 | 0.013 | 0.04 | Carboxypeptidase B inhibitor | |||
| 0.156 | 0.129 | 0.156 | Growth factor agonist | |||
| 0.033 | 0.006 | 0.033 | Progesterone agonist | 0.019 0.011 DBMET02114 | ||
| 0.07 | 0.043 | 0.07 | Glutamate (mGluR7) antagonist | |||
| 0.147 | 0.122 | 0.578 | P-glycoprotein inhibitor | 0.578 0.005 DBMET02114 | DBMET02114 | |
| 0.067 | 0.043 | 0.067 | Cannabinoid receptor agonist | |||
| 0.042 | 0.02 | 0.042 | Retinoid X receptor antagonist | |||
| 0.058 | 0.036 | 0.058 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.103 | 0.081 | 0.103 | Acetylcholine release stimulant | |||
| 0.041 | 0.019 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.026 | 0.005 | 0.026 | NMDA receptor phencyclidine site antagonist | |||
| 0.05 | 0.029 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.069 0.013 DBMET02114 | DBMET02114 | |
| 0.067 | 0.047 | 0.067 | MDM2 inhibitor | |||
| 0.038 | 0.018 | 0.038 | Retinoid X alpha receptor antagonist | |||
| 0.028 | 0.008 | 0.067 | Corticosteroid-like | 0.067 0.002 DBMET02114 | DBMET02114 | |
| 0.07 | 0.052 | 0.07 | Phospholipase D inhibitor | 0.066 0.063 DBMET02114 | ||
| 0.027 | 0.009 | 0.027 | Vitamin D receptor antagonist | 0.024 0.012 DBMET02114 | ||
| 0.17 | 0.152 | 0.192 | Nitric-oxide synthase stimulant | 0.192 0.103 DBMET02114 | DBMET02114 | |
| 0.042 | 0.024 | 0.042 | Membrane dipeptidase inhibitor | |||
| 0.035 | 0.018 | 0.035 | Cholesterol ester transfer protein antagonist | |||
| 0.065 | 0.049 | 0.065 | Neuronal nicotinic receptor antagonist | |||
| 0.018 | 0.003 | 0.018 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.027 | 0.012 | 0.027 | Retinoid X gamma receptor agonist | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.053 | 0.039 | 0.053 | GABA receptor antagonist | |||
| 0.029 | 0.015 | 0.029 | Nicotinic acid receptor 2 antagonist | |||
| 0.043 | 0.029 | 0.043 | Alpha 1L adrenoreceptor agonist | |||
| 0.055 | 0.041 | 0.087 | Argininosuccinate synthase inhibitor | 0.087 0.023 DBMET02114 | DBMET02114 | |
| 0.043 | 0.03 | 0.043 | Heme oxygenase inhibitor | |||
| 0.093 | 0.08 | 0.155 | AMP-activated protein kinase stimulant | 0.155 0.025 DBMET02114 | DBMET02114 | |
| 0.056 | 0.043 | 0.056 | Botulinum neurotoxin type A inhibitor | |||
| 0.082 | 0.07 | 0.114 | NADH dehydrogenase inhibitor | 0.114 0.032 DBMET02114 | DBMET02114 | |
| 0.028 | 0.016 | 0.028 | Retinoid X gamma receptor antagonist | |||
| 0.032 | 0.021 | 0.032 | ATP citrate lysase inhibitor | 0.031 0.023 DBMET02114 | ||
| 0.013 | 0.002 | 0.024 | Transcortin receptor antagonist | 0.024 0.001 DBMET02114 | DBMET02114 | |
| 0.067 | 0.057 | 0.067 | Epoxide hydrolase inhibitor | |||
| 0.026 | 0.016 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 DBMET02114 | DBMET02114 | |
| 0.023 | 0.014 | 0.023 | Retinoic acid gamma receptor agonist | |||
| 0.098 | 0.089 | 0.098 | Proteasome inhibitor | |||
| 0.037 | 0.028 | 0.037 | Glutamate (mGluR8) agonist | 0.036 0.03 DBMET02114 | ||
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 DBMET02114 | ||
| 0.056 | 0.048 | 0.089 | Carbamoyl phosphate synthetase inhibitor | 0.089 0.024 DBMET02114 | DBMET02114 | |
| 0.023 | 0.016 | 0.023 | Retinoic acid receptor agonist | |||
| 0.051 | 0.044 | 0.098 | Alcohol oxidase inhibitor | 0.098 0.019 DBMET02114 | DBMET02114 | |
| 0.036 | 0.029 | 0.036 | Delayed rectifier potassium channel blocker | |||
| 0.031 | 0.024 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.014 DBMET02114 | DBMET02114 | |
| 0.124 | 0.117 | 0.124 | GABA C receptor rho-2 antagonist | |||
| 0.139 | 0.132 | 0.139 | Non-steroidal antiinflammatory agent | |||
| 0.092 | 0.086 | 0.112 | Cystathionine beta-synthase inhibitor | 0.112 0.065 DBMET02114 | DBMET02114 | |
| 0.046 | 0.04 | 0.046 | HCV NS3/NS4A protease inhibitor | |||
| 0.048 | 0.042 | 0.048 | Aconitate hydratase inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor agonist | |||
| 0.065 | 0.061 | 0.065 | Porphobilinogen synthase inhibitor | |||
| 0.01 | 0.006 | 0.01 | Progesterone receptor A antagonist | |||
| 0.071 | 0.068 | 0.071 | Chymotrypsin inhibitor | |||
| 0.015 | 0.012 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.006 DBMET02114 | DBMET02114 | |
| 0.06 | 0.057 | 0.06 | Calcium channel P-type blocker | |||
| 0.052 | 0.05 | 0.052 | Cannabinoid CB1 receptor agonist | |||
| 0.076 | 0.074 | 0.076 | Falcipain 2 inhibitor | |||
| 0.038 | 0.036 | 0.043 | Kainate receptor agonist | 0.043 0.024 DBMET02114 | DBMET02114 | |
| 0.025 | 0.024 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET02114 | DBMET02114 | |
| 0.036 | 0.035 | 0.036 | Dopamine D5 agonist | |||
| 0.048 | 0.047 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.013 DBMET02114 | DBMET02114 | |
| 0.01 | 0.011 | 0.093 | Glucocorticoid agonist | 0.093 0.003 DBMET02114 | DBMET02114 | |
| 0.091 | 0.092 | 0.127 | Mucolytic | 0.127 0.048 DBMET02114 | DBMET02114 | |
| 0.046 | 0.048 | 0.067 | Acyl-CoA dehydrogenase inhibitor | 0.067 0.029 DBMET02114 | DBMET02114 | |
| 0.063 | 0.068 | 0.086 | Glutamate dehydrogenase inhibitor | 0.086 0.039 DBMET02114 | DBMET02114 | |
| 0.013 | 0.018 | 0.021 | Thromboxane A2 agonist | 0.021 0.005 DBMET02114 | DBMET02114 | |
| 0.007 | 0.015 | 0.022 | Thromboxane agonist | 0.022 0.004 DBMET02114 | DBMET02114 | |
| 0.008 | 0.017 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET02114 | DBMET02114 | |
| 0.082 | 0.093 | 0.141 | Expectorant | 0.141 0.039 DBMET02114 | DBMET02114 | |
| 0.017 | 0.029 | 0.027 | Prostaglandin F2 alpha agonist | 0.027 0.01 DBMET02114 | DBMET02114 | |
| 0.078 | 0.091 | 0.106 | Creatine kinase inhibitor | 0.106 0.053 DBMET02114 | DBMET02114 | |
| 0.023 | 0.037 | 0.031 | Purinergic P2Y15 antagonist | 0.031 0.016 DBMET02114 | DBMET02114 | |
| 0.059 | 0.074 | 0.131 | Antineoplastic antibiotic | 0.131 0.036 DBMET02114 | DBMET02114 | |
| 0.016 | 0.035 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 DBMET02114 | DBMET02114 | |
| 0.009 | 0.029 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 DBMET02114 | DBMET02114 | |
| 0.014 | 0.037 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET02114 | DBMET02114 | |
| 0.049 | 0.073 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.044 DBMET02114 | DBMET02114 | |
| 0.02 | 0.054 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET02114 | DBMET02114 | |
| 0.03 | 0.065 | 0.06 | Mannosidase inhibitor | 0.06 0.017 DBMET02114 | DBMET02114 | |
| 0.03 | 0.066 | 0.037 | Vanilloid 3 antagonist | 0.037 0.032 DBMET02114 | DBMET02114 | |
| 0.038 | 0.08 | 0.053 | Biliverdin reductase inhibitor | 0.053 0.049 DBMET02114 | DBMET02114 | |
| 0.077 | 0.126 | 0.102 | Alkylator | 0.102 0.086 DBMET02114 | DBMET02114 | |
| 0.036 | 0.086 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.038 DBMET02114 | DBMET02114 | |
| 0.041 | 0.096 | 0.056 | Purinergic P2X1 antagonist | 0.056 0.05 DBMET02114 | DBMET02114 | |
| 0.074 | 0.13 | 0.091 | Beta glucuronidase inhibitor | 0.091 0.086 DBMET02114 | DBMET02114 | |
| 0.116 | 0.18 | 0.165 | Hypolipemic | 0.165 0.123 DBMET02114 | DBMET02114 | |
| 0.012 | 0.089 | 0.026 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET02114 | DBMET02114 | |
| 0.051 | 0.129 | 0.074 | Carbonic anhydrase VI inhibitor | 0.074 0.066 DBMET02114 | DBMET02114 | |
| 0.088 | 0.173 | 0.3 | Angiogenesis stimulant | 0.3 0.049 DBMET02114 | DBMET02114 | |
| 0.044 | 0.146 | 0.097 | Monophenol monooxygenase inhibitor | 0.097 0.079 DBMET02114 | DBMET02114 | |
| 0.049 | 0.153 | 0.117 | Antineoplastic alkaloid | 0.117 0.039 DBMET02114 | DBMET02114 | |
| 0.072 | 0.2 | 0.104 | Interleukin 8 antagonist | 0.104 0.088 DBMET02114 | DBMET02114 | |
| 0.097 | 0.234 | 0.194 | Free radical scavenger | 0.194 0.103 DBMET02114 | DBMET02114 | |
| 0.082 | 0.225 | 0.125 | NOS3 expression enhancer | 0.125 0.106 DBMET02114 | DBMET02114 | |
| 0.05 | 0.229 | 0.141 | Lipid peroxidase inhibitor | 0.141 0.074 DBMET02114 | DBMET02114 | |
| 0.027 | 0.435 | 0.088 | Thioredoxin inhibitor | 0.088 0.064 DBMET02114 | DBMET02114 | |
| 0.063 | 0.78 | 0.188 | Peptidyltransferase inhibitor | 0.188 0.116 DBMET02114 | DBMET02114 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |